O	O	O	0	11	Stimulation	Stimulation	B-NP	NN	O	17	SUB	O
O	O	O	12	14	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	15	16	a	a	B-NP	DT	O	8	NMOD	O
O	O	O	17	22	human	human	I-NP	JJ	B-cell_line	8	NMOD	B-cell_line
O	O	O	23	24	T	T	I-NP	NN	I-cell_line	8	NMOD	I-cell_line
O	O	O	24	25	-	-	I-NP	HYPH	I-cell_line	8	P	I-cell_line
O	O	O	25	29	cell	cell	I-NP	NN	I-cell_line	8	NMOD	I-cell_line
O	O	O	30	35	clone	clone	I-NP	NN	I-cell_line	2	PMOD	I-cell_line
O	O	O	36	40	with	with	B-PP	IN	O	8	NMOD	O
O	O	O	41	45	anti	anti	B-NP	AFX	O	16	NMOD	O
O	O	O	45	46	-	-	I-NP	HYPH	O	16	NMOD	O
T2	B-Entity	B-Entity	46	49	CD3	CD3	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	50	52	or	or	O	CC	O	16	NMOD	O
O	O	O	53	58	tumor	tumor	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	59	67	necrosis	necrosis	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	68	74	factor	factor	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	O	75	82	induces	induce	B-VP	VBZ	O	0	ROOT	O
T3	B-Entity	B-Entity	83	85	NF	NF	B-NP	NN	B-protein	22	NMOD	B-protein
T3	I-Entity	I-Entity	85	86	-	-	I-NP	HYPH	I-protein	22	NMOD	I-protein
T3	I-Entity	I-Entity	86	91	kappa	kappa	I-NP	NN	I-protein	22	NMOD	I-protein
T3	I-Entity	I-Entity	92	93	B	B	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	O	94	107	translocation	translocation	I-NP	NN	O	29	NMOD	O
O	O	O	108	111	but	but	B-CONJP	CC	O	29	NMOD	O
O	O	O	112	115	not	not	I-CONJP	RB	O	23	DEP	O
T4	B-Entity	B-Entity	116	121	human	human	B-NP	JJ	B-DNA	29	NMOD	B-DNA
T4	I-Entity	I-Entity	122	138	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	29	NMOD	I-DNA
T4	I-Entity	I-Entity	139	144	virus	virus	I-NP	NN	I-DNA	29	NMOD	I-DNA
T4	I-Entity	I-Entity	145	146	1	1	I-NP	CD	I-DNA	29	NMOD	I-DNA
T4	I-Entity	I-Entity	147	155	enhancer	enhancer	I-NP	NN	I-DNA	32	NMOD	I-DNA
O	O	O	155	156	-	-	B-NP	HYPH	O	32	NMOD	O
O	O	O	156	165	dependent	dependent	I-NP	JJ	O	32	NMOD	O
O	O	O	166	179	transcription	transcription	I-NP	NN	O	17	OBJ	O
O	O	O	179	180	.	.	O	.	O	17	P	O

O	O	O	182	185	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	186	196	expression	expression	I-NP	NN	O	33	NMOD	O
O	O	O	197	199	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	200	211	transiently	transiently	B-NP	RB	O	5	AMOD	O
O	O	O	212	223	transfected	transfecte	I-NP	VBN	O	7	NMOD	O
O	O	O	224	234	expression	expression	I-NP	NN	O	7	NMOD	O
O	O	O	235	242	vectors	vector	I-NP	NNS	O	3	PMOD	O
O	O	O	243	248	under	under	B-PP	IN	O	2	NMOD	O
O	O	O	249	252	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	253	260	control	control	I-NP	NN	O	8	PMOD	O
O	O	O	261	263	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	264	267	the	the	B-NP	DT	O	15	NMOD	O
T5	B-Entity	B-Entity	268	272	long	long	I-NP	JJ	B-DNA	15	NMOD	B-DNA
T5	I-Entity	I-Entity	273	281	terminal	terminal	I-NP	JJ	I-DNA	15	NMOD	I-DNA
T5	I-Entity	I-Entity	282	288	repeat	repeat	I-NP	NN	I-DNA	30	NMOD	I-DNA
O	O	O	289	290	(	(	O	(	O	18	DEP	O
T6	B-Entity	B-Entity	290	293	LTR	LTR	B-NP	NN	B-DNA	18	DEP	B-DNA
O	O	O	293	294	)	)	O	)	O	15	NMOD	O
O	O	O	295	297	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	298	301	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	302	307	human	human	I-NP	JJ	O	23	NMOD	O
O	O	O	308	324	immunodeficiency	immunodeficiency	I-NP	NN	O	23	NMOD	O
O	O	O	325	330	virus	virus	I-NP	NN	O	19	PMOD	O
O	O	O	331	332	(	(	O	(	O	26	DEP	O
O	O	O	332	335	HIV	HIV	B-NP	NN	O	26	DEP	O
O	O	O	335	336	)	)	O	)	O	23	NMOD	O
O	O	O	337	339	or	or	O	CC	O	30	NMOD	O
O	O	O	340	343	its	its	B-NP	PRP$	O	30	NMOD	O
T7	B-Entity	B-Entity	344	352	enhancer	enhancer	I-NP	NN	B-DNA	30	NMOD	B-DNA
T7	I-Entity	I-Entity	353	361	sequence	sequence	I-NP	NN	I-DNA	11	PMOD	I-DNA
O	O	O	362	365	and	and	O	CC	O	33	NMOD	O
O	O	O	366	369	the	the	B-NP	DT	O	33	NMOD	O
O	O	O	370	383	translocation	translocation	I-NP	NN	O	45	SUB	O
O	O	O	384	386	of	of	B-PP	IN	O	33	NMOD	O
O	O	O	387	390	the	the	B-NP	DT	O	37	NMOD	O
T8,T9	B-Entity,B-Entity	B-Entity,B-Entity	391	394	HIV	HIV	I-NP	NN	B-DNA	37	NMOD	B-DNA
T8,T9	I-Entity,I-Entity	I-Entity,I-Entity	395	403	enhancer	enhancer	I-NP	NN	I-DNA	34	PMOD	I-DNA
T8	I-Entity	I-Entity	403	404	-	-	O	HYPH	O	33	P	O
T8	I-Entity	I-Entity	404	411	binding	bind	B-VP	VBG	O	33	NMOD	O
T8	I-Entity	I-Entity	412	419	protein	protein	B-NP	NN	O	44	NMOD	O
T10	I-Entity	I-Entity	420	422	NF	NF	I-NP	NN	B-protein	44	NMOD	B-protein
T10	I-Entity	I-Entity	422	423	-	-	B-NP	HYPH	I-protein	44	NMOD	I-protein
T10	I-Entity	I-Entity	423	428	kappa	kappa	I-NP	NN	I-protein	44	NMOD	I-protein
T10	I-Entity	I-Entity	429	430	B	B	I-NP	NN	I-protein	39	OBJ	I-protein
O	O	O	431	435	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	436	444	analyzed	analyze	I-VP	VBN	O	45	VC	O
O	O	O	445	447	in	in	B-PP	IN	O	46	VMOD	O
O	O	O	448	451	two	two	B-NP	CD	O	53	NMOD	O
O	O	O	452	457	human	human	I-NP	JJ	B-cell_line	53	NMOD	B-cell_line
O	O	O	458	459	T	T	I-NP	NN	I-cell_line	53	NMOD	I-cell_line
O	O	O	459	460	-	-	I-NP	HYPH	I-cell_line	53	NMOD	I-cell_line
O	O	O	460	464	cell	cell	I-NP	NN	I-cell_line	53	NMOD	I-cell_line
O	O	O	465	471	clones	clone	I-NP	NNS	I-cell_line	47	PMOD	I-cell_line
O	O	O	472	482	stimulated	stimulate	B-VP	VBN	O	53	NMOD	O
O	O	O	483	490	through	through	B-PP	IN	O	54	VMOD	O
O	O	O	491	496	their	their	B-NP	PRP$	O	61	NMOD	O
T11	B-Entity	B-Entity	497	498	T	T	I-NP	NN	B-protein	61	NMOD	B-protein
T11	I-Entity	I-Entity	498	499	-	-	I-NP	HYPH	I-protein	61	NMOD	I-protein
T11	I-Entity	I-Entity	499	503	cell	cell	I-NP	NN	I-protein	61	NMOD	I-protein
T11	I-Entity	I-Entity	504	512	receptor	receptor	I-NP	NN	I-protein	61	NMOD	I-protein
T11	I-Entity	I-Entity	513	520	complex	complex	I-NP	NN	I-protein	55	PMOD	I-protein
O	O	O	521	523	or	or	B-PP	CC	O	55	PMOD	O
O	O	O	524	526	by	by	B-PP	IN	O	55	PMOD	O
O	O	O	527	532	tumor	tumor	B-NP	NN	B-protein	66	NMOD	B-protein
O	O	O	533	541	necrosis	necrosis	I-NP	NN	I-protein	66	NMOD	I-protein
O	O	O	542	548	factor	factor	I-NP	NN	I-protein	68	NMOD	I-protein
O	O	O	549	551	or	or	O	CC	O	68	NMOD	O
O	O	O	552	559	phorbol	phorbol	B-NP	NN	O	74	NMOD	O
O	O	O	560	562	12	12	I-NP	CD	O	68	NMOD	O
O	O	O	562	563	-	-	O	HYPH	O	74	NMOD	O
O	O	O	563	572	myristate	myristate	B-NP	NN	B-protein	74	NMOD	B-protein
O	O	O	573	575	13	13	I-NP	CD	I-protein	71	NMOD	I-protein
O	O	O	575	576	-	-	I-NP	HYPH	O	71	P	O
O	O	O	576	583	acetate	acetate	I-NP	NN	O	63	PMOD	O
O	O	O	583	584	.	.	O	.	O	45	P	O

O	O	O	585	587	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	588	593	found	find	B-VP	VBD	O	0	ROOT	O
O	O	O	594	595	a	a	B-NP	DT	O	4	NMOD	O
O	O	O	596	608	dissociation	dissociation	I-NP	NN	O	2	OBJ	O
O	O	O	609	611	of	of	B-PP	IN	O	4	NMOD	O
T12	B-Entity	B-Entity	612	614	NF	NF	B-NP	NN	B-protein	10	NMOD	B-protein
T12	I-Entity	I-Entity	614	615	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T12	I-Entity	I-Entity	615	620	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T12	I-Entity	I-Entity	621	622	B	B	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	O	623	636	translocation	translocation	I-NP	NN	O	5	PMOD	O
O	O	O	637	641	from	from	B-PP	IN	O	4	NMOD	O
O	O	O	642	657	transactivation	transactivation	B-NP	NN	O	11	PMOD	O
O	O	O	658	660	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	661	667	either	either	O	CC	O	21	NMOD	O
O	O	O	668	671	the	the	B-NP	DT	O	17	NMOD	O
T13	B-Entity	B-Entity	672	675	HIV	HIV	I-NP	NN	B-DNA	17	NMOD	B-DNA
T13	I-Entity	I-Entity	676	679	LTR	LTR	I-NP	NN	I-DNA	21	NMOD	I-DNA
O	O	O	680	682	or	or	O	CC	O	21	NMOD	O
O	O	O	683	686	the	the	B-NP	DT	O	21	NMOD	O
T14	B-Entity	B-Entity	687	690	HIV	HIV	I-NP	NN	B-DNA	21	NMOD	B-DNA
T14	I-Entity	I-Entity	691	699	enhancer	enhancer	I-NP	NN	I-DNA	13	PMOD	I-DNA
O	O	O	699	700	.	.	O	.	O	2	P	O

T1	B-Protein	B-Protein	701	712	Interleukin	Interleukin	B-NP	NN	B-protein	3	SUB	B-protein
T1	I-Protein	I-Protein	713	714	2	2	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	O	715	722	induced	induce	B-VP	VBD	O	0	ROOT	O
O	O	O	723	736	proliferation	proliferation	B-NP	NN	O	14	NMOD	O
O	O	O	737	740	but	but	B-NP	CC	O	14	NMOD	O
O	O	O	741	744	not	not	I-NP	RB	O	5	DEP	O
T15	B-Entity	B-Entity	745	747	NF	NF	B-NP	NN	B-protein	11	NMOD	B-protein
T15	I-Entity	I-Entity	747	748	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T15	I-Entity	I-Entity	748	753	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
T15	I-Entity	I-Entity	754	755	B	B	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	O	756	769	translocation	translocation	I-NP	NN	O	14	NMOD	O
O	O	O	770	772	or	or	O	CC	O	14	NMOD	O
T16	B-Entity	B-Entity	773	776	LTR	LTR	B-NP	NN	B-DNA	14	NMOD	B-DNA
O	O	O	777	792	transactivation	transactivation	I-NP	NN	O	3	OBJ	O
O	O	O	792	793	.	.	O	.	O	3	P	O

O	O	O	794	801	Phorbol	Phorbol	B-NP	NN	O	2	NMOD	O
O	O	O	802	807	ester	ester	I-NP	NN	O	6	NMOD	O
O	O	O	808	810	or	or	O	CC	O	6	NMOD	O
O	O	O	811	819	specific	specific	B-NP	JJ	O	6	NMOD	O
O	O	O	820	827	antigen	antigen	I-NP	NN	O	6	NMOD	O
O	O	O	828	839	recognition	recognition	I-NP	NN	O	7	SUB	O
O	O	O	840	847	induced	induce	B-VP	VBD	O	0	ROOT	O
T17	B-Entity	B-Entity	848	851	HIV	HIV	B-NP	NN	B-DNA	10	NMOD	B-DNA
T17	I-Entity	I-Entity	852	855	LTR	LTR	I-NP	NN	I-DNA	10	NMOD	I-DNA
O	O	O	856	871	transactivation	transactivation	I-NP	NN	O	7	OBJ	O
O	O	O	871	872	,	,	O	,	O	7	P	O
O	O	O	873	880	whereas	whereas	O	IN	O	7	VMOD	O
O	O	O	881	892	stimulation	stimulation	B-NP	NN	O	22	SUB	O
O	O	O	893	897	with	with	B-PP	IN	O	13	NMOD	O
O	O	O	898	903	tumor	tumor	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	O	904	912	necrosis	necrosis	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	O	913	919	factor	factor	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	920	922	or	or	O	CC	O	19	NMOD	O
O	O	O	923	931	antibody	antibody	B-NP	NN	O	14	PMOD	O
O	O	O	932	934	to	to	B-PP	TO	O	19	NMOD	O
T18	B-Entity	B-Entity	935	938	CD3	CD3	B-NP	NN	B-protein	20	PMOD	B-protein
O	O	O	939	942	did	do	B-VP	VBD	O	12	SBAR	O
O	O	O	943	946	not	not	O	RB	O	22	VMOD	O
O	O	O	946	947	.	.	O	.	O	7	P	O

O	O	O	948	951	The	The	B-NP	DT	O	4	NMOD	O
O	O	O	952	955	two	two	I-NP	CD	O	4	NMOD	O
O	O	O	956	962	latter	latter	I-NP	JJ	O	4	NMOD	O
O	O	O	963	970	signals	signal	I-NP	NNS	O	5	SUB	O
O	O	O	971	975	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	976	988	nevertheless	nevertheless	B-ADJP	RB	O	5	VMOD	O
O	O	O	989	993	able	able	I-ADJP	JJ	O	5	PRD	O
O	O	O	994	996	to	to	B-VP	TO	O	9	VMOD	O
O	O	O	997	1003	induce	induce	I-VP	VB	O	7	AMOD	O
T19	B-Entity	B-Entity	1004	1006	NF	NF	B-NP	NN	B-protein	14	NMOD	B-protein
T19	I-Entity	I-Entity	1006	1007	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
T19	I-Entity	I-Entity	1007	1012	kappa	kappa	I-NP	NN	I-protein	14	NMOD	I-protein
T19	I-Entity	I-Entity	1013	1014	B	B	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	1015	1028	translocation	translocation	I-NP	NN	O	9	OBJ	O
O	O	O	1029	1033	with	with	B-PP	IN	O	9	VMOD	O
O	O	O	1034	1035	a	a	B-NP	DT	O	17	NMOD	O
O	O	O	1036	1043	pattern	pattern	I-NP	NN	O	15	PMOD	O
O	O	O	1044	1046	in	in	B-PP	IN	O	17	NMOD	O
O	O	O	1047	1050	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	1051	1055	band	band	I-NP	NN	O	23	NMOD	O
O	O	O	1055	1056	-	-	B-NP	HYPH	O	23	NMOD	O
O	O	O	1056	1061	shift	shift	I-NP	NN	O	23	NMOD	O
O	O	O	1062	1067	assay	assay	I-NP	NN	O	18	PMOD	O
O	O	O	1068	1085	indistinguishable	indistinguishable	B-ADJP	JJ	O	23	NMOD	O
O	O	O	1086	1090	from	from	B-PP	IN	O	24	AMOD	O
O	O	O	1091	1095	that	that	B-NP	DT	O	25	PMOD	O
O	O	O	1096	1104	observed	observe	B-VP	VBN	O	26	NMOD	O
O	O	O	1105	1110	using	use	B-VP	VBG	O	5	VMOD	O
O	O	O	1111	1118	phorbol	phorbol	B-NP	NN	O	30	NMOD	O
O	O	O	1119	1124	ester	ester	I-NP	NN	O	28	OBJ	O
O	O	O	1124	1125	.	.	O	.	O	5	P	O

O	O	O	1126	1129	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	1130	1137	finding	finding	I-NP	NN	O	32	SUB	O
O	O	O	1138	1142	that	that	B-SBAR	IN	O	2	NMOD	O
O	O	O	1143	1152	induction	induction	B-NP	NN	O	18	SUB	O
O	O	O	1153	1155	of	of	B-PP	IN	O	4	NMOD	O
T20	B-Entity	B-Entity	1156	1158	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T20	I-Entity	I-Entity	1158	1159	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T20	I-Entity	I-Entity	1159	1164	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T20	I-Entity	I-Entity	1165	1166	B	B	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	O	1167	1169	by	by	B-PP	IN	O	4	NMOD	O
O	O	O	1170	1175	tumor	tumor	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	1176	1184	necrosis	necrosis	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	1185	1191	factor	factor	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	O	1192	1194	or	or	O	CC	O	15	NMOD	O
O	O	O	1195	1203	antibody	antibody	B-NP	NN	O	10	PMOD	O
O	O	O	1204	1206	to	to	B-PP	TO	O	15	NMOD	O
T21	B-Entity	B-Entity	1207	1210	CD3	CD3	B-NP	NN	B-protein	16	PMOD	B-protein
O	O	O	1211	1213	is	be	B-VP	VBZ	O	3	SBAR	O
O	O	O	1214	1217	not	not	O	RB	O	18	VMOD	O
O	O	O	1218	1228	sufficient	sufficient	B-ADJP	JJ	O	18	PRD	O
O	O	O	1229	1231	to	to	B-VP	TO	O	22	VMOD	O
O	O	O	1232	1238	induce	induce	I-VP	VB	O	18	VMOD	O
T22	B-Entity	B-Entity	1239	1242	HIV	HIV	B-NP	NN	B-DNA	24	NMOD	B-DNA
T22	I-Entity	I-Entity	1243	1251	enhancer	enhancer	I-NP	NN	I-DNA	27	NMOD	I-DNA
O	O	O	1251	1252	-	-	B-NP	HYPH	O	27	NMOD	O
O	O	O	1252	1261	dependent	dependent	I-NP	JJ	O	27	NMOD	O
O	O	O	1262	1275	transcription	transcription	I-NP	NN	O	22	OBJ	O
O	O	O	1276	1278	in	in	B-PP	IN	O	22	VMOD	O
O	O	O	1279	1285	cloned	clone	B-NP	VBN	B-cell_line	31	NMOD	B-cell_line
O	O	O	1286	1287	T	T	I-NP	NN	I-cell_line	31	NMOD	I-cell_line
O	O	O	1288	1293	cells	cell	I-NP	NNS	I-cell_line	28	PMOD	I-cell_line
O	O	O	1294	1303	contrasts	contrast	B-VP	VBZ	O	0	ROOT	O
O	O	O	1304	1308	with	with	B-PP	IN	O	32	VMOD	O
O	O	O	1309	1316	results	result	B-NP	NNS	O	33	PMOD	O
O	O	O	1317	1325	obtained	obtain	B-VP	VBN	O	34	NMOD	O
O	O	O	1326	1328	in	in	B-PP	IN	O	35	VMOD	O
O	O	O	1329	1333	most	most	B-NP	JJS	O	42	NMOD	O
O	O	O	1334	1348	lymphoblastoid	lymphoblastoid	I-NP	JJ	B-cell_line	42	NMOD	B-cell_line
O	O	O	1349	1350	T	T	I-NP	NN	I-cell_line	42	NMOD	I-cell_line
O	O	O	1350	1351	-	-	B-NP	HYPH	I-cell_line	42	NMOD	I-cell_line
O	O	O	1351	1355	cell	cell	I-NP	NN	I-cell_line	42	NMOD	I-cell_line
O	O	O	1356	1361	lines	line	I-NP	NNS	I-cell_line	36	PMOD	I-cell_line
O	O	O	1362	1365	and	and	O	CC	O	32	VMOD	O
O	O	O	1366	1375	indicates	indicate	B-VP	VBZ	O	32	VMOD	O
O	O	O	1376	1380	that	that	B-SBAR	IN	O	44	VMOD	O
O	O	O	1381	1387	normal	normal	B-NP	JJ	B-cell_type	48	NMOD	B-cell_type
O	O	O	1388	1389	T	T	I-NP	NN	I-cell_type	48	NMOD	I-cell_type
O	O	O	1390	1401	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	49	SUB	I-cell_type
O	O	O	1402	1408	differ	differ	B-VP	VBP	O	45	SBAR	O
O	O	O	1409	1413	from	from	B-PP	IN	O	49	VMOD	O
O	O	O	1414	1421	tumoral	tumoral	B-NP	JJ	B-cell_type	53	NMOD	B-cell_type
O	O	O	1422	1423	T	T	I-NP	NN	I-cell_type	53	NMOD	I-cell_type
O	O	O	1424	1429	cells	cell	I-NP	NNS	I-cell_type	50	PMOD	I-cell_type
O	O	O	1430	1432	in	in	B-PP	IN	O	49	VMOD	O
O	O	O	1433	1438	terms	term	B-NP	NNS	O	54	PMOD	O
O	O	O	1439	1441	of	of	B-PP	IN	O	55	NMOD	O
O	O	O	1442	1454	requirements	requirement	B-NP	NNS	O	56	PMOD	O
O	O	O	1455	1458	for	for	B-PP	IN	O	57	NMOD	O
T23	B-Entity	B-Entity	1459	1462	HIV	HIV	B-NP	NN	B-DNA	61	NMOD	B-DNA
T23	I-Entity	I-Entity	1463	1466	LTR	LTR	I-NP	NN	I-DNA	61	NMOD	I-DNA
O	O	O	1467	1477	activation	activation	I-NP	NN	O	58	PMOD	O
O	O	O	1477	1478	.	.	O	.	O	32	P	O

O	O	O	1479	1490	Furthermore	Furthermore	B-ADVP	RB	O	5	VMOD	O
O	O	O	1490	1491	,	,	O	,	O	5	P	O
O	O	O	1492	1495	our	our	B-NP	PRP$	O	4	NMOD	O
O	O	O	1496	1503	results	result	I-NP	NNS	O	5	SUB	O
O	O	O	1504	1511	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	1512	1516	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	O	1517	1523	events	event	B-NP	NNS	O	26	SUB	O
O	O	O	1524	1530	linked	link	B-VP	VBN	O	7	NMOD	O
O	O	O	1531	1533	to	to	B-PP	TO	O	8	VMOD	O
O	O	O	1534	1535	T	T	B-NP	NN	O	13	NMOD	O
O	O	O	1535	1536	-	-	I-NP	HYPH	O	13	NMOD	O
O	O	O	1536	1540	cell	cell	I-NP	NN	O	13	NMOD	O
O	O	O	1541	1551	activation	activation	I-NP	NN	O	9	PMOD	O
O	O	O	1551	1552	,	,	O	,	O	7	P	O
O	O	O	1553	1555	in	in	B-PP	IN	O	7	NMOD	O
O	O	O	1556	1564	addition	addition	B-NP	NN	O	15	PMOD	O
O	O	O	1565	1567	to	to	B-PP	TO	O	16	NMOD	O
T24	B-Entity	B-Entity	1568	1570	NF	NF	B-NP	NN	B-protein	22	NMOD	B-protein
T24	I-Entity	I-Entity	1570	1571	-	-	B-NP	HYPH	I-protein	22	NMOD	I-protein
T24	I-Entity	I-Entity	1571	1576	kappa	kappa	I-NP	NN	I-protein	22	NMOD	I-protein
T24	I-Entity	I-Entity	1577	1578	B	B	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	O	1579	1592	translocation	translocation	I-NP	NN	O	24	NMOD	O
O	O	O	1593	1596	per	per	B-ADVP	FW	O	24	NMOD	O
O	O	O	1597	1599	se	se	I-ADVP	FW	O	17	PMOD	O
O	O	O	1599	1600	,	,	O	,	O	7	P	O
O	O	O	1601	1607	induce	induce	B-VP	VBP	O	6	SBAR	O
O	O	O	1608	1618	functional	functional	B-NP	JJ	O	28	NMOD	O
O	O	O	1619	1631	interactions	interaction	I-NP	NNS	O	26	OBJ	O
O	O	O	1632	1634	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	1635	1638	the	the	B-NP	DT	O	35	NMOD	O
T25	B-Entity	B-Entity	1639	1641	NF	NF	I-NP	NN	B-protein	35	NMOD	B-protein
T25	I-Entity	I-Entity	1641	1642	-	-	B-NP	HYPH	I-protein	35	NMOD	I-protein
T25	I-Entity	I-Entity	1642	1647	kappa	kappa	I-NP	NN	I-protein	35	NMOD	I-protein
T25	I-Entity	I-Entity	1648	1649	B	B	I-NP	NN	I-protein	35	NMOD	I-protein
T25	I-Entity	I-Entity	1650	1657	complex	complex	I-NP	NN	I-protein	29	PMOD	I-protein
O	O	O	1658	1662	with	with	B-PP	IN	O	26	VMOD	O
O	O	O	1663	1666	the	the	B-NP	DT	O	39	NMOD	O
T26	B-Entity	B-Entity	1667	1670	HIV	HIV	I-NP	NN	B-DNA	39	NMOD	B-DNA
T26	I-Entity	I-Entity	1671	1679	enhancer	enhancer	I-NP	NN	I-DNA	36	PMOD	I-DNA
O	O	O	1679	1680	.	.	O	.	O	5	P	O
